Infectious Diseases
Project for International Cooperation
CHALLENGES AND INNOVATIVE SOLUTIONS FOR THE CONTROL OF INFECTIOUS DISEASES IN URBAN AREAS
Start date: 01/08/2018
End date: 31/07/2022
Description
The turbulent growth of cities became a great topic of debate in the academia and in the government, especially in the formulation of public policies for urban planning. Attached to this process of turbulent urbanization is the population growth, not controlled by planning, which, since the industrial revolution, makes people get together in cities not prepared to welcome them, creating slums in unhealthy areas, subject to risk factors, making it difficult to control endemic diseases, and, unfortunately, creating the conditions for diseases and epidemics related to the lack of hygiene and sanitation. The identification of new infectious agents and the resurgence of diseases, which were considered to be controlled, create “emerging and re-emerging diseases”, which along with the effects of aging and urban violence, became the center of attention of health professionals, scientists and managers of public policies. Based on this idea, the graduate programs which integrate this theme intend to strengthen their collaboration and cooperation with universities in the USA (Boston University, Case Western Reserve University, Rutger New Jersey Medical School, University of California – Berkeley and Johns Hopkins University), England (London College University), and to develop a transnational project, with the following objectives: 1) characterize and validate biomarkers of high risk for the progression of active TB; 2) create models or strategies for intervention which may cause impact in the control of tuberculosis, dengue and sexually transmitted diseases; 3) develop, assess and validate new methodologies for the diagnosis of tuberculosis and other bacterial infections; 4) evaluate (in vitro) the action of new chemical compounds (synthetized by researchers at UFES) on the main species of bacteria which are relevant in a clinical view; 5) assess new therapeutic procedures for the treatment of infectious diseases.
